{
  "paper_metadata": {
    "pmid": "35936037",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the role of the KCNH2 gene in Long QT Syndrome (LQTS) and the potential of hERG channel activators as a therapeutic strategy. It mentions several variants in the KCNH2 gene associated with LQT2 but does not provide detailed penetrance data or individual case studies."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.R56Q",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "",
        "phenotype": "LQT2-associated"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Corrects for effects of trafficking deficient LQT2-associated R56Q hERG.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Main text, section on hERG channel activators",
      "additional_notes": "",
      "key_quotes": [
        "cLQTS: corrects for effects of trafficking deficient LQT2-associated R56Q hERG."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.N470D",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "",
        "phenotype": "LQT2-associated"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "ICA-105574 could activate both the LQT2-associated hERG mutants N470D and G601S.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Main text, section on hERG channel activators",
      "additional_notes": "",
      "key_quotes": [
        "ICA-105574 could activate both the LQT2-associated hERG mutants N470D and G601S but with threefold reduced potency compared with WT."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.G601S",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "",
        "phenotype": "LQT2-associated"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "ICA-105574 could activate both the LQT2-associated hERG mutants N470D and G601S.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Main text, section on hERG channel activators",
      "additional_notes": "",
      "key_quotes": [
        "ICA-105574 could activate both the LQT2-associated hERG mutants N470D and G601S but with threefold reduced potency compared with WT."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.T983I",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": null,
        "demographics": "",
        "phenotype": "Variant of uncertain significance"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Effective against the variant of uncertain significance (VUS) KCNH2 T983I.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Main text, section on hERG channel activators",
      "additional_notes": "",
      "key_quotes": [
        "Effective against the variant of uncertain significance (VUS) KCNH2 T983I."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "medium",
    "challenges": [
      "The paper did not provide detailed penetrance data or individual case studies."
    ],
    "notes": "The extraction focused on variants mentioned in the context of hERG channel activators and their potential therapeutic effects."
  }
}